The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives
Authors
Keywords
-
Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 191, Issue -, Pages 114614
Publisher
Elsevier BV
Online
2022-11-06
DOI
10.1016/j.addr.2022.114614
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multipotent Poly(Tertiary Amine‐Oxide) Micelles for Efficient Cancer Drug Delivery
- (2022) Jiajia Xiang et al. Advanced Science
- PEGylated Liposomes Accumulate in the Areas Relevant to Skin Toxicities via Passive Extravasation across “Leaky” Endothelium
- (2022) Yue Li et al. ACS Nano
- Strategies to improve the EPR effect: A mechanistic perspective and clinical translation
- (2022) Mayumi Ikeda-Imafuku et al. JOURNAL OF CONTROLLED RELEASE
- Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms
- (2022) Yixuan Zi et al. ADVANCED DRUG DELIVERY REVIEWS
- The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
- (2021) Mukaddes Izci et al. CHEMICAL REVIEWS
- Tumor Microenvironment Remodeling-Based Penetration Strategies to Amplify Nanodrug Accessibility to Tumor Parenchyma
- (2021) Yanhong Liu et al. ADVANCED DRUG DELIVERY REVIEWS
- Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors
- (2021) Li Liu et al. MOLECULES
- Multifunctional biomolecule nanostructures for cancer therapy
- (2021) Jing Wang et al. Nature Reviews Materials
- Enhanced tumour penetration and prolonged circulation in blood of polyzwitterion–drug conjugates with cell-membrane affinity
- (2021) Siqin Chen et al. Nature Biomedical Engineering
- The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery—Personal Remarks and Future Prospects
- (2021) Hiroshi Maeda Journal of Personalized Medicine
- Obstacles and opportunities in a forward vision for cancer nanomedicine
- (2021) Irene de Lázaro et al. NATURE MATERIALS
- Vascular Bursts Act as a Versatile Tumor Vessel Permeation Route for Blood‐Borne Particles and Cells
- (2021) Kazunori Igarashi et al. Small
- Turning down the heat: The case for mild hyperthermia and thermosensitive liposomes
- (2021) Maximilian Regenold et al. Nanomedicine-Nanotechnology Biology and Medicine
- A Size‐Changeable Collagenase‐Modified Nanoscavenger for Increasing Penetration and Retention of Nanomedicine in Deep Tumor Tissue
- (2020) Funeng Xu et al. ADVANCED MATERIALS
- Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments
- (2020) Paz de la Torre et al. MOLECULES
- The entry of nanoparticles into solid tumours
- (2020) Shrey Sindhwani et al. NATURE MATERIALS
- Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo
- (2020) Lu Zhang et al. Nature Nanotechnology
- Enzyme-Triggered Transcytosis of Dendrimer–Drug Conjugate for Deep Penetration into Pancreatic Tumors
- (2020) Guowei Wang et al. ACS Nano
- Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy
- (2020) Quan Zhou et al. BIOMATERIALS
- A nanoparticle’s pathway into tumours
- (2020) Irene de Lázaro et al. NATURE MATERIALS
- Active transcytosis and new opportunities for cancer nanomedicine
- (2020) Subehndu Pandit et al. NATURE MATERIALS
- Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
- (2020) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy
- (2020) Michael Dunne et al. ADVANCED DRUG DELIVERY REVIEWS
- Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
- (2020) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Active Transportation of Liposome Enhances Tumor Accumulation, Penetration, and Therapeutic Efficacy
- (2020) Guowei Wang et al. Small
- Nitric Oxide‐Driven Nanomotor for Deep Tissue Penetration and Multidrug Resistance Reversal in Cancer Therapy
- (2020) Mi Mi Wan et al. Advanced Science
- Transport of nanoparticles across the endothelial cell layer
- (2020) Tore Skotland et al. Nano Today
- Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges
- (2019) Victor M. Pulgar Frontiers in Neuroscience
- Nanoparticles promote in vivo breast cancer cell intravasation and extravasation by inducing endothelial leakiness
- (2019) Fei Peng et al. Nature Nanotechnology
- Hyaluronic Acid-Based Activatable Nanomaterials for Stimuli-Responsive Imaging and Therapeutics: Beyond CD44-Mediated Drug Delivery
- (2019) Ki Young Choi et al. ADVANCED MATERIALS
- Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy
- (2019) Quan Zhou et al. Nature Nanotechnology
- Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors
- (2019) Assaf Zinger et al. ACS Nano
- Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine
- (2019) Amanda K. Pearce et al. BIOCONJUGATE CHEMISTRY
- Perspectives on the past, present, and future of cancer nanomedicine
- (2018) Yu Seok Youn et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor targeting via EPR: Strategies to enhance patient responses
- (2018) Susanne K. Golombek et al. ADVANCED DRUG DELIVERY REVIEWS
- RGD peptide-based non-viral gene delivery vectors targeting integrin αvβ3 for cancer therapy
- (2018) Shuang Fu et al. JOURNAL OF DRUG TARGETING
- Near infrared fluorescent peptide nanoparticles for enhancing esophageal cancer therapeutic efficacy
- (2018) Zhen Fan et al. Nature Communications
- Progress and challenges towards targeted delivery of cancer therapeutics
- (2018) Daniel Rosenblum et al. Nature Communications
- Parameters Affecting the Enhanced Permeability and Retention Effect: The Need for Patient Selection
- (2017) Az Alddien Natfji et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Nanoparticle-mediated local depletion of tumour-associated platelets disrupts vascular barriers and augments drug accumulation in tumours
- (2017) Suping Li et al. Nature Biomedical Engineering
- A phase I study of doxorubicin-loaded anti-EGFR immunoliposomes in patients with advanced solid tumors.
- (2017) C. Mamot et al. JOURNAL OF CLINICAL ONCOLOGY
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
- (2016) Yuko Nakamura et al. BIOCONJUGATE CHEMISTRY
- Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors
- (2016) D. D. Von Hoff et al. CLINICAL CANCER RESEARCH
- Targeting collagen for diagnostic imaging and therapeutic delivery
- (2016) Hendra Wahyudi et al. JOURNAL OF CONTROLLED RELEASE
- To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
- (2016) F. Danhier JOURNAL OF CONTROLLED RELEASE
- A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy-Problems, Solutions, and Prospects
- (2016) Hiroshi Maeda et al. MICROCIRCULATION
- Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery
- (2016) Yu Matsumoto et al. Nature Nanotechnology
- Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
- (2015) Hiroshi Maeda ADVANCED DRUG DELIVERY REVIEWS
- Drug radiotherapy combinations: Review of previous failures and reasons for future optimism
- (2015) Geoff S. Higgins et al. CANCER TREATMENT REVIEWS
- Improving drug delivery to solid tumors: Priming the tumor microenvironment
- (2015) Iftikhar Ali Khawar et al. JOURNAL OF CONTROLLED RELEASE
- Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
- (2015) Andreas Wicki et al. JOURNAL OF CONTROLLED RELEASE
- Effects of Tumor Microenvironment Heterogeneity on Nanoparticle Disposition and Efficacy in Breast Cancer Tumor Models
- (2014) G. Song et al. CLINICAL CANCER RESEARCH
- Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls
- (2014) Hideaki Nakamura et al. Expert Opinion on Drug Delivery
- Nanopharmaceuticals (part 1): products on the market
- (2014) Volkmar Weissig et al. International Journal of Nanomedicine
- A clinical update of using albumin as a drug vehicle — A commentary
- (2014) Felix Kratz JOURNAL OF CONTROLLED RELEASE
- Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging
- (2014) Benjamin Theek et al. JOURNAL OF CONTROLLED RELEASE
- EPR: Evidence and fallacy
- (2014) Joseph W. Nichols et al. JOURNAL OF CONTROLLED RELEASE
- Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
- (2014) J. E. Zuckerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Two-Wave Nanotherapy To Target the Stroma and Optimize Gemcitabine Delivery To a Human Pancreatic Cancer Model in Mice
- (2013) Huan Meng et al. ACS Nano
- Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate
- (2013) Ruth Duncan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
- (2013) U. Prabhakar et al. CANCER RESEARCH
- Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor
- (2013) D. T. Wiley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE–cadherin
- (2013) M.I. Setyawati et al. Nature Communications
- Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
- (2012) Sebastien Taurin et al. JOURNAL OF CONTROLLED RELEASE
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
- (2012) Vikash P. Chauhan et al. Nature Nanotechnology
- The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
- (2012) Mert Erkan et al. Nature Reviews Gastroenterology & Hepatology
- Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting
- (2012) Hiroshi MAEDA PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
- (2011) Twan Lammers et al. JOURNAL OF CONTROLLED RELEASE
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Regulation of Endothelial Permeability via Paracellular and Transcellular Transport Pathways
- (2010) Yulia Komarova et al. Annual Review of Physiology
- Tumors as Organs: Complex Tissues that Interface with the Entire Organism
- (2010) Mikala Egeblad et al. DEVELOPMENTAL CELL
- Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies
- (2010) Chryso Kanthou et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
- (2010) Silverio Tomao International Journal of Nanomedicine
- The extracellular matrix at a glance
- (2010) C. Frantz et al. JOURNAL OF CELL SCIENCE
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
- (2009) H. Jarvelainen et al. PHARMACOLOGICAL REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now